Document Detail


Photocoagulation of the endometrium with the Nd:YAG laser for the treatment of menorrhagia. A report of ten cases.
MedLine Citation:
PMID:  3754283     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Nd-YAG laser photocoagulation was performed on ten patients with chronic menorrhagia in an attempt to either decrease the menstrual flow sufficiently to obviate the need for hysterectomy or to obtain amenorrhea. The entire endometrial lining was treated, from the fundus down to 4 cm from the external cervical os. A blanching technique was accomplished by holding the fiber tip 5-10 mm from the endometrial surface. Patients were followed for an average of 12 months. All noted a marked reduction in the amount of menstrual flow; two became amenorrheic. One patient subsequently underwent hysterectomy for a preexisting uterine prolapse and progressive symptoms of dyspareunia and pelvic pain.
Authors:
J M Lomano
Related Documents :
9130733 - Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonis...
20832103 - Endometrial effects of exemestane compared to tamoxifen within the tamoxifen exemestane...
24678813 - Experience with a gonadotrophin-releasing hormone agonist prior to myomectomy - compari...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of reproductive medicine     Volume:  31     ISSN:  0024-7758     ISO Abbreviation:  J Reprod Med     Publication Date:  1986 Feb 
Date Detail:
Created Date:  1986-05-06     Completed Date:  1986-05-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0173343     Medline TA:  J Reprod Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  148-50     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Danazol / therapeutic use
Endometrium / pathology,  surgery*
Female
Follow-Up Studies
Humans
Hysterectomy, Vaginal
Laser Therapy*
Light Coagulation*
Medroxyprogesterone / therapeutic use
Menorrhagia / drug therapy,  surgery*
Middle Aged
Postoperative Period
Chemical
Reg. No./Substance:
17230-88-5/Danazol; 520-85-4/Medroxyprogesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Compression systems for hearing aids and cochlear prostheses.
Next Document:  Quinazoline antifolates inhibiting thymidylate synthase: benzoyl ring modifications.